経口5-アミノレブリン酸誘導性膀胱腫瘍経尿道的切除術における持続的術中低血圧の術者別差異：後ろ向き観察研究
Yoshifumi Katsumata1, Shinkuro Yamamoto2, Hideki Iwata1
1Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.
Objectives:
Severe intraoperative hypotension is frequently reported during transurethral resection of bladder tumor (TURBT) using orally administered 5-aminolevulinic acid hydrochloride (5-ALA); however, the influence of anesthetic technique on prolonged hypotensive episodes remains unclear.
Methods:
We retrospectively analyzed 423 consecutive patients who underwent oral 5-ALA-guided TURBT between 2018 and 2024. Sustained hypotension was defined as mean arterial pressure <65 mmHg lasting ≥30 min. Baseline characteristics, anesthetic variables, and hemodynamic parameters were compared between patients with and without sustained hypotension. Multivariable logistic regression was used to identify independent predictors.
Results:
Among patients receiving general anesthesia (n=274), the incidence of sustained hypotension varied significantly depending on the anesthetic agent (p=0.02). In multivariable logistic regression, remimazolam was independently associated with a significantly lower risk of sustained hypotension compared with sevoflurane (adjusted OR 0.35, 95% CI 0.14-0.83, p=0.02).
Conclusions:
Approximately one-fourth of patients undergoing oral 5-ALA-guided TURBT experienced sustained intraoperative hypotension, with spinal anesthesia showing a lower incidence than general anesthesia. Longer anesthesia and surgical durations increased the risk. The choice of anesthetic agents under general anesthesia also appeared to affect the risk of sustained hypotension. These findings highlight the importance of individualized anesthetic management to maintain hemodynamic stability during this procedure.
